Daily as of 4 Nov 16:00 ET
- Price
- above both $930.67 vs 50 $800.69 / 200 $740.82
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 3 Sep 2026 · projected 29 bars out
REGN | Regeneron PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$930.67
-$42.69 (-4.39%)
Regeneron Pharmaceuticals (REGN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $927.89 vs 50 $743.30 / 200 $780.73
- Projection
- 🟨Golden cross projected in 14 bars
- Test
- No active test
- Last cross
- 💀Death cross week of 14 Jul 2025 · projected 28 bars out
4-hour as of 4 Nov 16:00 ET
- Price
- above both $930.67 vs 50 $799.86 / 200 $750.86
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 7 Aug 2026 · projected 30 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 3 Sep 2026 | 🟨Golden steep | daily | 29 bars out | Not tested |
| 7 Aug 2026 | 🟨Golden | 4-hour | 30 bars out | Not tested |
| 11 Jun 2026 | 💀Death steep | daily | 21 bars out | Not tested |
| 9 Apr 2026 | 💀Death | 4-hour | 7 bars out | 4 bar cross test |
| 13 Nov 2025 | 🟨Golden moderate | daily | 13 bars out | Not tested |
About REGN
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$497M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge